Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Low Glycaemic Index,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : German Sport University, Cologne
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigating the Effects of Diet and Physical Activity on Esport Performance
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 30, 2023
Lead Product(s) : Low Glycaemic Index,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : German Sport University, Cologne
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : New Prebiotic Follow-On Formula,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Universitair Ziekenhuis Brussel
Deal Size : Inapplicable
Deal Type : Inapplicable
Prebiotic Effects in Healthy Toddlers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 24, 2023
Lead Product(s) : New Prebiotic Follow-On Formula,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Universitair Ziekenhuis Brussel
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Isomaltulose,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Swansea University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 29, 2022
Lead Product(s) : Isomaltulose,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Swansea University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Prebiotic,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Prebiotics on Intestinal Colonization and Mood in a University Cohort
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
January 28, 2022
Lead Product(s) : Prebiotic,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Prebiotic,Inapplicable
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 10, 2021
Lead Product(s) : Prebiotic,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitalose,Isomaltulose
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of Blood Glucose and Insulin Response After Intake of Vitalose
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 22, 2020
Lead Product(s) : Vitalose,Isomaltulose
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Isomaltulose,Inapplicable
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
June 14, 2019
Lead Product(s) : Isomaltulose,Inapplicable
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Prebiotic Fructan,Inapplicable
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Recipient : Xinhua Hospital, Shanghai Jiaotong University School of Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Prebiotic Fructans Effect on 1-3 Years Constipated Children's Bowel Habits
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 08, 2019
Lead Product(s) : Prebiotic Fructan,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Recipient : Xinhua Hospital, Shanghai Jiaotong University School of Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Carbohydrate-Based Breakfast,Protein-Based Breakfast
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : German Institute of Human Nutrition
Deal Size : Inapplicable
Deal Type : Inapplicable
Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 16, 2019
Lead Product(s) : Carbohydrate-Based Breakfast,Protein-Based Breakfast
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : German Institute of Human Nutrition
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Oligofructose-Enriched Inulin,Inapplicable
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Recipient : Children's Hospital of Philadelphia
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 31, 2018
Lead Product(s) : Oligofructose-Enriched Inulin,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Recipient : Children's Hospital of Philadelphia
Deal Size : Inapplicable
Deal Type : Inapplicable